Prostate Cancer Test
Published on Feb 13 2010, in the categories: Test Info
It has been launched a prostate cancer test which can detect the first signs of prostate cancer in just 10 minutes. In other words, the prostate cancer test evaluates in a very short time the level of blood of a certain indicator of prostate cancer, which is called PSA- the Prostate Specific Antigen.
Before this test was available on the market, men were forced to wait for several days before they received the test results. The Prostate Specific Antigen is a protein which is released by the prostate when it is affected by a possible disease. A high level of Prostate Specific Antigen does not necessarily mean the patient has prostate cancer, but it can suggest the necessity of further investigation.
The new test, called Prostate Specific Antigen Watch, makes the medical investigation procedure easier and brings new benefits by saving a substantial number of lives. In order to make this kind of test, the doctors only need a small amount of your blood which will be then tested with the help of a portable device. Normal prostate cancer tests require sending the sanguine tests to a special lab, in order to analyze the samples.
Doctor Tim Larner, specialist at the Brighton University and University Hospital in Sussex, believe doctors are already counting very much on the prostate cancer test in Great Britain and that this test became one of the most important criteria of diagnose. This test will be very useful for patient who have to permanently supervise their Prostate Specific Antigen level or for patients who need regular monitoring of the disease’s evolution or treatment’s success. For these people, any delay can cause anxiety and useless stress, according to doctor Larner.
Mediwatch drug producer announced last year that they have discovered another urine test, called PCA3Plus, which can be more precise in detecting prostate cancer. This test detects another molecular indicator of the prostate cancer. The two tests, used together, can change the life of ill men who are suspected of prostate cancer. This simple blood test allows doctors to quickly identify people who have an increased risk of developing prostate cancer and who need further investigation, while the PCA3Plus helps them to identify the prostate cancer risk after an unclear biopsy test, according to doctor Larner.
After taking this simple blood test, the patients are then asked to go to a specialist, depending on the Prostate Specific Antigen test results. But these are not the only results taken into account. There are also other factors which are taken into account by doctors, such as the age and the medical history of the patient’s family.
Measuring the Prostate Specific Antigen level also represents a vital way of monitoring the progresses made by prostate cancer patients which have been diagnosed with this disease. In Great Britain, approximately 34.000 men are diagnosed annually with prostate cancer. From those, 10.000 die because of prostate cancer. The prostate cancer is the most frequent cancer type on men and it represents a quarter of the new cancer types diagnosed on men around the world.
Before this test was available on the market, men were forced to wait for several days before they received the test results. The Prostate Specific Antigen is a protein which is released by the prostate when it is affected by a possible disease. A high level of Prostate Specific Antigen does not necessarily mean the patient has prostate cancer, but it can suggest the necessity of further investigation.
The new test, called Prostate Specific Antigen Watch, makes the medical investigation procedure easier and brings new benefits by saving a substantial number of lives. In order to make this kind of test, the doctors only need a small amount of your blood which will be then tested with the help of a portable device. Normal prostate cancer tests require sending the sanguine tests to a special lab, in order to analyze the samples.
Doctor Tim Larner, specialist at the Brighton University and University Hospital in Sussex, believe doctors are already counting very much on the prostate cancer test in Great Britain and that this test became one of the most important criteria of diagnose. This test will be very useful for patient who have to permanently supervise their Prostate Specific Antigen level or for patients who need regular monitoring of the disease’s evolution or treatment’s success. For these people, any delay can cause anxiety and useless stress, according to doctor Larner.
Mediwatch drug producer announced last year that they have discovered another urine test, called PCA3Plus, which can be more precise in detecting prostate cancer. This test detects another molecular indicator of the prostate cancer. The two tests, used together, can change the life of ill men who are suspected of prostate cancer. This simple blood test allows doctors to quickly identify people who have an increased risk of developing prostate cancer and who need further investigation, while the PCA3Plus helps them to identify the prostate cancer risk after an unclear biopsy test, according to doctor Larner.
After taking this simple blood test, the patients are then asked to go to a specialist, depending on the Prostate Specific Antigen test results. But these are not the only results taken into account. There are also other factors which are taken into account by doctors, such as the age and the medical history of the patient’s family.
Measuring the Prostate Specific Antigen level also represents a vital way of monitoring the progresses made by prostate cancer patients which have been diagnosed with this disease. In Great Britain, approximately 34.000 men are diagnosed annually with prostate cancer. From those, 10.000 die because of prostate cancer. The prostate cancer is the most frequent cancer type on men and it represents a quarter of the new cancer types diagnosed on men around the world.
If you liked this post, subscribe to our blog by filling your e-mail address below:
Want to add something? Post your comments